Study: PET/MRI shows promise in restaging of prostate cancer

12/26/2012 | AuntMinnie.com (free registration)

Choline-PET/MRI identified more suspicious lesions compared with PET/CT in 31 patients with recurrent prostate cancer, according to a study presented at a radiology meeting. The study also found that PET/MRI performs comparably with PET/CT in identifying lymph node metastases and bone metastases. The findings indicate a fully diagnostic choline-PET/MRI protocol for restaging prostate cancer is well-tolerated and feasible in patients, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC